ADA Scientific Sessions 2026 Abstract

The Association of Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) with Cardiovascular Outcomes in People with Type 2 Diabetes from the UK Clinical Practice Research Datalink (CPRD)

By Gilberte Martine-Edith, Jonah J C Thomas, Safoora Gharibzadeh, Pratik Choudhary

Study in peopleInterventions

The paper

Gilberte Martine-Edith, Jonah J C Thomas, Safoora Gharibzadeh, Pratik Choudhary

Leicester

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1824-P

doi.org/10.2337/db26-1824-p

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs